StockData
Transcode Therapeutics, Inc. logo

Transcode Therapeutics, Inc. (RNAZ) stock

RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.41+0.06 (+4.44%)

Close on Nov 17, 2026Market cap $1.43MP/E –Yield –

Transcode Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Transcode Therapeutics's market cap was $1.42M on Nov 11, 2026, against $7.74M a year earlier. Over the last 5 years it ranged from $418.48K to $1.37T, with a median of $3.79B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.42M-75.1%
2025Dec 31, 2025$5.69M-99.7%
2024Dec 31, 2024$1.63B-97.5%
2023Dec 29, 2023$65.11B-79.8%
2022Dec 30, 2022$322.87B-73.4%
2021Dec 31, 2021$1.21T–

More Transcode Therapeutics figures

See a number that looks wrong?